https://www.theglobalfund.org/data/rss-feeds/latest/ /en/news/2026/2026-04-23-global-fund-launches-regional-malaria-grant-southern-africa/ The Global Fund today announced a new phase in the fight against malaria in southern Africa, launching the MOSASWA multi-country grant alongside additional emergency and weather-responsive investments to address rising malaria risks across the region. The announcement comes ahead of World Malaria Day, underscoring the urgency of accelerating progress toward elimination. Thu, 23 Apr 2026 12:00:00 GMT https://www.forbes.com/sites/petersands/2026/04/23/where-bullets-fly-malaria-kills/ In a camp in Darfur, an infant develops a fever. All too often, the cause is malaria, a disease that flourishes in the chaos of conflict. If the family can access prompt diagnosis and treatment, the child is unlikely to develop a severe case of the disease, let alone die. But time is of the essence. Survival rates plummet if the parasite is left undetected and untreated for more than a couple of days. Where health care facilities have been destroyed, medical supply chains disrupted and health workers overwhelmed by the sheer volume of cases, too many children are dying because conflict prevents timely access to care. Thu, 23 Apr 2026 12:00:00 GMT https://globalfund.exposure.co/kenya-risks-a-resurgence-of-malaria-these-children-are-trying-to-stop-it Just before dawn, students stream through the bright pink gates of St. Anne’s Ahero Comprehensive School in Kisumu County in western Kenya. It’s the start of a school day – and the mosquitoes are hungry. Clouds of them descend from the dense canopy of trees growing high above the school yard. In the pre-dawn darkness, even more mosquitoes crowd around classroom doors, waiting for a chance to bite. Mon, 20 Apr 2026 12:00:00 GMT /en/events/world-malaria-day/ The fight to end malaria is at a critical juncture. After years of progress, momentum has stalled – putting millions of people at risk, especially pregnant women and children under 5. Mon, 20 Apr 2026 12:00:00 GMT /en/updates/2026/2026-04-14-us-global-fund-expand-commitment-long-acting-hiv-prevention-country-rollout-lenacapavir-accelerates/ The United States and the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) today announced an expanded commitment to scale up access to long-acting lenacapavir (LEN) for HIV pre-exposure prophylaxis (PrEP), aiming to reach an additional 1 million people over the next three years. Building on the original commitment, this brings the total joint ambition to 3 million people reached with LEN through 2028. Tue, 14 Apr 2026 12:00:00 GMT https://globalfund.exposure.co/in-eswatini-an-hiv-breakthrough-delivered At 24, Sandra is building her future. She owns two small beauty salons in and around Mbabane, Eswatini, and is saving up to pursue a degree in computer science. Taking control of her health is part of her plan, in a country where 1 in every 9 young women is HIV positive. When Sandra learned about lenacapavir – a twice-yearly injectable form of pre-exposure prophylaxis (PrEP) that is nearly 100% effective at preventing HIV – she didn’t hesitate. Wed, 08 Apr 2026 12:00:00 GMT /en/news/2026/2026-03-27-global-fund-approves-emergency-tb-funding-sudan/ The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has approved US$1,607,729 in emergency funding to support urgent tuberculosis (TB) diagnosis and treatment for internally displaced persons (IDPs) and host communities in Sudan through 31 December 2026. This funding will be implemented by the United Nations Development Programme (UNDP), in collaboration with the Federal Ministry of Health's National TB Programme and local organizations. Fri, 27 Mar 2026 12:00:00 GMT /en/stories/2026/2026-03-26-wahyu-agung-pratama/ At Sulianti Saroso Infectious Disease Hospital in Jakarta, laboratory teams routinely process samples from patients who could be ill with an infectious disease. Working safely with these biological samples requires specialized equipment and strict procedures designed to prevent accidental exposure in the laboratory. Thu, 26 Mar 2026 12:00:00 GMT /en/stories/2026/2026-03-26-dr-aster-shweaamare/ For more than two decades, Dr. Aster Shweaamare has been one of the driving forces behind Ethiopia’s fight against HIV. At the Zewditu Memorial Hospital in Addis Ababa, one of Ethiopia’s largest HIV treatment centers, she leads the disease prevention team and helps oversee care for more than 7,000 patients. Up to 200 people visit the clinic each day for testing, treatment and support. Thu, 26 Mar 2026 12:00:00 GMT /en/stories/2026/2026-03-26-fatoumata-keita/ When Fatoumata Keita was a young girl, an accident changed the course of her life. After her family sought treatment from a traditional healer, the care she received left her with a permanent disability in her left arm. The experience stayed with her – and inspired her to pursue a career in science and health care. Thu, 26 Mar 2026 12:00:00 GMT